Social Media Ideas for Cpcrx

Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity

<![CDATA[Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo]]>

Market Digest: CP, BBWI

AAPC Launches CPC-M Credential, the Highest Standard of Mastery in Medical Coding

New certification recognizes experienced medical coding professionals whose expertise drives compliance, revenue integrity, and organizational leadership SALT LAKE CITY, July 8, 20...

Comstock Capital Value Fund Q1 2026 Commentary

Market Digest: CNP, KHC, DOCU

Photocure ASA (PHCUF) M&A Call Transcript

PGP: Falling To A Discount Makes This An Attractive PIMCO Offering

This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million

This clinical-stage biotech develops oral therapeutics for chronic diseases, with a pipeline centered on metabolic and pulmonary targets.

GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion

PGIM Corporate Bond 0-5 Year ETF declares $0.1815 dividend

CP Axtra Public Company Limited (CPXTF) Presents at TISCO Corporate Day 2026 - Slideshow

Option Care (OPCH) Climbs 5.9% on US Healthcare Developments

Cục Quản lý Dược xử phạt Công ty CPC1 Hà Nội vì vi phạm lưu hành thuốc

Cục Quản lý Dược xử phạt Công ty Cổ phần Dược phẩm CPC1 Hà Nội do vi phạm quy định về lưu hành thuốc, liên quan đến 10 loại thuốc.Công...

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at...

Columbia Contrarian Core Fund Q1 2026 Commentary

Invesco Core Plus Bond Fund Q1 2026 Commentary

<![CDATA[Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion]]>

CVS to cover Eli Lilly’s anti-obesity pill, reinstate Zepbound later this year

CVS will cover Eli Lilly’s anti-obesity pill next month, reinstate Zepbound later this year, and keep Wegovy access for Caremark members.

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase

Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.

The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments (rerun)

This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders....

<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>

CVS Caremark reaches settlement with FTC over insulin suit

Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost ver...

Why This Pharmaceutical Stock Jumped Close to 100% This Week

It is getting acquired by a larger firm in the sector.